Insulin Detemir

Brand name: Levemir Flexpen

Rank #48 of 500 drugs by total cost

Data: CMS Medicare Part D, 2023 (most current available) · Updated March 2026

$376.5M

Total Cost

Share:

548,216

Total Claims

$376.5M

Total Cost

22,992

Prescribers

$687

Cost per Claim

46,427

Beneficiaries

858,955

30-Day Fills

$16K

Avg Cost/Provider

24

Avg Claims/Provider

Share of Medicare Part D Spending

0.14%

of total Medicare Part D spending

$376.5M of $275.65B

Top Prescribers by Cost

Top 10 prescribers of $376.5M total

🔎 Data Overview

📊

Ranked #48 out of 500 drugs tracked by total cost. Insulin Detemir represents a significant portion of Medicare drug spending.

👤

Average cost of $8,110 per patient per year. Medications at this price point significantly impact patient out-of-pocket costs and Medicare spending.

Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.

Top Prescribers of Insulin Detemir

#ProviderSpecialtyLocationClaimsCost
1Tiffany BennettNurse PractitionerCorinth, MS296$451K
2Somera AliEndocrinologyLimerick, PA364$321K
3Mohamed ZeitounEndocrinologyHobart, IN233$299K
4Mohammad IjazEndocrinologyZanesville, OH242$290K
5Prabhat TandonEndocrinologySummerfield, FL283$288K
6Ashley ScottFamily PracticeCoweta, OK416$273K
7Stacy CongdonNurse PractitionerJohnson City, NY211$271K
8Todd FulcherFamily PracticeJackson, MS652$264K
9Kenneth SluisInternal MedicineLewiston, ME188$255K
10Jaweed AkhterEndocrinologyBeaumont, TX192$242K
11Najmuddin KarimjeeInternal MedicineHouston, TX207$239K
12Alisha MasonNurse PractitionerRipley, MS170$234K
13Hemlata MoturiEndocrinologyPittsburgh, PA200$206K
14Michael SatchellFamily PracticeAlbany, GA1,197$201K
15Dewey BaileyEndocrinologyRoanoke, VA168$200K

Top prescribers ranked by total cost for this drug in 2023.

Related Drugs by Cost

#DrugTotal CostClaims
45Deutetrabenazine (Austedo)$404.1M60,532
46Linagliptin (Tradjenta)$403.8M519,439
47Macitentan (Opsumit)$394.6M30,889
48Insulin Detemir (Levemir Flexpen)$376.5M548,216
49Aripiprazole (Aripiprazole)$373.1M1,494,971
50Apalutamide (Erleada)$369.2M24,956
51Secukinumab (Cosentyx Sensoready (2 Pens))$347.7M45,496

Related Analysis

Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology